Sigilon Therapeutics logo
Sigilon Therapeutics SGTX
$ 22.47 0.0%

Quarterly report 2023-Q2
added 08-07-2023

report update icon

Sigilon Therapeutics Cash Flow 2011-2024 | SGTX

Annual Cash Flow Sigilon Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-51.5 M -78.4 M -61.6 M - - - - - - - - -

Depreciation & Amortization

1.26 M 1.12 M 854 K - - - - - - - - -

Accounts Payables

936 K 2.34 M - - - - - - - - - -

Accounts Receivables

2.17 M 59 K - - - - - - - - - -

Total Inventories

- - - - - - - - - - - -

All numbers in USD currency

Quarterly Cash Flow Sigilon Therapeutics

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- -11.4 M - -44.3 M - -19.5 M - -61 M - -22.7 M - -44.5 M -31.5 M -15.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

300 K 315 K - 300 K 300 K 316 K - 300 K 300 K 247 K - 200 K 200 K 202 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Payables

1.11 M 1.33 M 936 K 1.41 M - 2.04 M 2.34 M 3.23 M 4.66 M 2.01 M 1.99 M 1.99 M 1.99 M 1.99 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Receivables

4.5 M 3.16 M 2.17 M 23 K - 62 K 59 K 27 K 178 K 140 K 177 K 177 K 177 K 177 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency